Assay of isomerised and/or optically inverted proteins and protein fragments
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 15, 2009
Grant Date -
Dec 23, 2004
app pub date -
May 22, 2002
filing date -
May 23, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
In an in vitro diagnostic test for osteoarthritis or rheumatoid arthritis, the amount or presence in a sample of anisomerised or optically inverted protein fragment is measured which derives from perlecan, bigylcan, decorin, fibrillin-1 or protocadherin or which is a specific sequence from aggrecan, type II collagen, COMP or CILP.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully